Bryan Lawrence

Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS.

Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.

Diglife /VC/ (Digilife) is a venture capital firm founded by Bobba Venkatadri. The firm is headquartered in San Francisco, California.

Chemwerth, Inc. develops and supplies pharmaceutical products. The company offers oral, injectable, veterinary, oncology, topical, investigational stage, and in development stage products. It also offers a range of services, including regulatory affairs and technical service department, as well as customs clearance and logistics support services. The company was founded by Peter J. Werth Jr in 1982 and is headquartered in Woodbridge, CT.

Cohere-Med, Inc. is a healthcare company based in Burlingame, CA that uses data science to optimize clinical outcomes through augmented clinical decision analytics. The private company's solutions include Sepsis Watch, Mortality Model, and Cardiac Decompensation, which accurately predict in-hospital mortality and identify high-risk cardiac decompensation phenotypes via real-time EHR data. Cohere-Med's analytics are successfully delivering care since late 2019 in Duke and other installations, resulting in increased bundle compliance, lower average length of stay, lower mortality, and improved clinical outcomes. The company's analytics stand out from traditional analytics by using a database of millions of clinical parameters of over 42,000 patients at Duke, resulting in true evidence-based medicine.

Part of P.&R. The company is based in Parsippany, NJ. The website is intended for use by US residents only. S.p.A, Fidia Pharma USA, Inc. is a pharmaceutical company. The company's product portfolio includes hyaluronic acid-based viscosupplement products. Fidia is committed to compliantly assisting its customers to ensure a smooth transition from WAC-based to ASP-based reimbursement. Fidia Pharma USA is a wholly owned subsidiary of Fidia Farmaceutici S.p.A, which was founded in 1946.

Veriskin, Inc. develops and manufactures medical devices for skin cancer diagnostics. The company was founded by Mirianas Chachisvilis, Eugene Tu and Carl Edman and is headquartered in San Diego, CA.

Fight Cancer Global, LLC provides a network platform aimed at solving the isolation problems faced by cancer patients. The private company is based in Houston, TX.

HealthOnLine provides national e-commerce, e-care delivery and personalized information services. The company is headquartered in Washington, DC.

dMedClinical Co. Ltd., formerly known as Caidya, is a leading clinical research organization that offers medical writing services for clinical trials. The company is based in Shanghai, CN, and has subsidiaries in Germany, Switzerland, United States, United Kingdom, and China. The Chinese company uses a combination of industry-recognized, proprietary, and third-party technologies to ensure transparency and cost efficiency in clinical trials. The company specializes in infectious disease clinical trial services and provide expertise for therapeutic developments. dMedClinical Co. was founded in 2021 by Ling Shi Tan, who has been the CEO since then.

MEDecision, Inc. engages in healthcare management software and services to physicians and managed care organizations. Its solutions include integrated medical management, regional health information organization, collaborative data exchange, and collaboracare consortium. The company was founded by David St Clair on October 28,1988 and is headquartered in Wayne, PA.

St. Luke's-Roosevelt Hospital Center owns and operates a hospital. It provides services in the areas of emergency, pediatric emergency, pre-hospital care and medical toxicology. The company was founded in 1979 and is headquartered in New York, NY.

InfoLogix, Inc. develops mobility and advanced wireless asset tracking solutions. It operates within the Stanley Security Solutions business platform. The firm provides strategic consulting, business applications, wireless device and infrastructure, connectivity, and mobile managed service solutions. The company was founded by Richard D. Hodge and David T. Gulian in 2001 and is headquartered in Hatboro, PA.

AdvantEdge Healthcare Solutions, Inc. provides medical billing and practice management services. It serves specialty physicians, surgery centers, medical billing companies, and hospitals. The firm offers billing, coding, pricing, performance, reporting and dashboards, compliance and consulting solutions. The company was founded in 1999 and is headquartered in Warren, NJ.

VirMedica, Inc. provides technology solutions which designed to optimize the commercialization of specialty pharmaceutical products. It is an innovative holding company bringing together complimentary businesses for the specific purpose of redefining the market access landscape for specialty products. The company’s technology solution offers an end-to-end transformational platform to optimize specialty product commercialization and management. The company was founded by Mark K. Barnes in 2013 and is headquartered in Boston, MA.

The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023.

The Bellevue Hospital provides health care services, contemporary medicine with hometown caring. The firm provides health services include diabetes education, cardiac rehab & cardiac comeback support group, cardiopulmonary care & rehabilitation, centralized scheduling, clyde health clinic, heart failure clinic, home health care, lifeline emergency phone services, northwest Ohio medical equipment company, occupational health center, plastic surgery, Rehabilitation services, and sleep disorders center. The company was founded in 1914 and is headquartered in Bellevue, OH.

MedRhythms, Inc. is a digital therapeutics company based in Portland, ME. The company uses sensors, music, and software to develop evidence-based neurologic interventions to measure and improve walking. MedRhythms is dedicated to developing direct-stimulation digital therapeutics that provide direct stimulation to enable the mechanism of action in each relevant population. The company has an active pipeline of prescription digital therapeutics targeting rehabilitation and prevention in areas of neurologic injury and disease. The company's platform combines sensors, software, and music with advanced neuroscience to target neural circuitry. MedRhythms is on a mission to help people living with neurologic injuries and diseases optimize their health and independence through next-generation therapeutics to improve brain health. MedRhythms was founded in 2013 by Brian Harris and Owen McCarth, with Brian Harris serving as the CEO since then.

Nuance Designs of CT LLC is a private company that specializes in designing and developing auto-injectors and self-injection devices. The company is based in Woodbridge, CT.

VM Pharma LLC develops and identifies allosteric kinase inhibitors. The firm specializes in the treatment of pain, cancer, and other human diseases. The company is headquartered in Fremont, CA.

Alzeca Biosciences, Inc. is a company based in Houston, TX. Alzeca is developing a proprietary intravenous contrast agent that targets Alzheimer's disease pathology. The company's targeted agent has shown the ability to detect early stage disease pathology with exceptional resolution and sensitivity using commonly available imaging techniques. The development of the agent was initiated through a collaboration between Dr. Ananth Annapragada and Dr. Jason Eriksen. The company was founded in 2012 by Jason Eriksen, Robin Mansukhani, Ananth Annapragada. The CEO is Carlo Giovanni Medici.